Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a cohort analysis for recurrent glioblastoma multiforme

Eleftherios Archavlis, Nikolaos Tselis, Jasmin Kraft, Gerhard Birn, Peter Ulrich, Dimos Baltas & Nikolaos Zamboglou
Objective: Tumor recurrence of glioblastoma multiforme (GBM) after initial treatment with surgical resection, radiotherapy, and chemotherapy is an inevitable phenomenon. This retrospective cohort study compared the efficacy of interstitial high dose rate brachytherapy (HDR-BRT), re-resection and dense[for full text, please go to the a.m. URL]